rs771215852

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021098.3(CACNA1H):​c.3652G>A​(p.Asp1218Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000156 in 1,597,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D1218D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.12

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.044415504).
BP6
Variant 16-1209320-G-A is Benign according to our data. Variant chr16-1209320-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 529555.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High AC in GnomAdExome4 at 23 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.3613G>A p.Asp1205Asn missense_variant Exon 17 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.3613G>A p.Asp1205Asn missense_variant Exon 17 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3652G>A p.Asp1218Asn missense_variant Exon 17 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1565G>A non_coding_transcript_exon_variant Exon 17 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3099G>A non_coding_transcript_exon_variant Exon 16 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3652G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*1565G>A 3_prime_UTR_variant Exon 17 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3099G>A 3_prime_UTR_variant Exon 16 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000176
AC:
4
AN:
227704
AF XY:
0.0000237
show subpopulations
Gnomad AFR exome
AF:
0.0000729
Gnomad AMR exome
AF:
0.0000293
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000954
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000159
AC:
23
AN:
1445530
Hom.:
0
Cov.:
31
AF XY:
0.0000153
AC XY:
11
AN XY:
719572
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33432
American (AMR)
AF:
0.0000448
AC:
2
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26064
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39634
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86170
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38476
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111160
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152222
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41464
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.00000852
AC:
1
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
May 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jul 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
12
DANN
Benign
0.86
DEOGEN2
Benign
0.064
T;.;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.45
T;T;T;.
M_CAP
Pathogenic
0.46
D
MetaRNN
Benign
0.044
T;T;T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
-3.5
N;.;N;N
PhyloP100
4.1
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
3.5
N;.;N;N
REVEL
Benign
0.27
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;.;T;T
Polyphen
0.0
B;.;B;B
Vest4
0.26
MutPred
0.31
Loss of ubiquitination at K1213 (P = 0.0193);.;Loss of ubiquitination at K1213 (P = 0.0193);Loss of ubiquitination at K1213 (P = 0.0193);
MVP
0.41
ClinPred
0.018
T
GERP RS
-0.94
Varity_R
0.039
gMVP
0.38
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771215852; hg19: chr16-1259320; API